SciELO - Scientific Electronic Library Online

 
vol.22 número3Evaluación de parámetros de banda ancha en la determinación de dominancia cerebral durante la hipnosisCapacitación sobre diabetes mellitus a familiares de personas afectadas de un consejo popular índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


MEDISAN

versión On-line ISSN 1029-3019

Resumen

HERRERO AGUIRRE, Hidelisa de la Caridad et al. Effectiveness of Oleozón® in the treatment of children and adolescents with giardiasis. MEDISAN [online]. 2018, vol.22, n.3, pp.279-286. ISSN 1029-3019.

A clinical assay in phase IV was carried out to evaluate the effectiveness of oral Oleozón® used in children and adolescents with giardiasis, assisted in the Pediatrics specialty consultation from "Julián Grimau García" University Polyclinic in Santiago de Cuba, from January to December, 2015. The universe was constituted by 116 patients (with the same number of cases and controls) and aged 1 to 18 years, infected by Giardia lamblia who presented abdominal pain, vomit and anorexy as fundamental symptoms. In the series it was obtained that the highest number in the patients of the experimental group whose therapeutic schedule included Oleozón® , solved the abdominal pain and it improved their general state when decreasing the rest of the symptoms. It could be concluded that the Oleozón® was effective in the treatment against giardiasis, because the samples of faeces were negative in all cases; besides, it produced no adverse reactions and its cost is low, what bears an economic, social and environmental impact

Palabras clave : Oleozón®; Giardia lamblia; giardiasis; children; adolescents; Pediatrics visit; effectiveness.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons